Current and future trends in transfusion therapy

Area of Science:

• Hematology
• Oncology
• Transfusion Medicine

Background:

• Intensive cancer treatments have significantly influenced blood product transfusion practices.
• While blood product screening reduces infection risk, it remains a concern.
• Transfusion guidelines, though often institution-specific, share universal principles.

Purpose of the Study:

• To review current transfusion practices for platelets, white blood cells, and red blood cells in oncology.
• To discuss the risks associated with blood product transfusions, including infection and transfusion-associated graft-versus-host disease.
• To highlight the importance of laboratory studies, patient assessment, administration, and education.

Main Methods:

• Review of current scientific literature and clinical guidelines on blood product transfusions.
• Discussion of laboratory studies relevant to transfusion efficacy and safety.
• Analysis of patient assessment, blood product administration protocols, and patient education strategies.

Main Results:

• Current transfusion approaches are dynamic and subject to ongoing evaluation.
• Despite screening, transfusion-acquired infections and transfusion-associated graft-versus-host disease remain potential risks.
• Effective patient assessment, administration, and education are crucial components of safe transfusion therapy.

Conclusions:

• Pediatric oncology nurses require up-to-date knowledge of evolving transfusion practices.
• Optimizing patient care in oncology necessitates staying informed about advancements in blood product transfusion.
• Continuous evaluation and adaptation of transfusion protocols are essential for patient safety and effective treatment.